Skip to main content
Log in

Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Enhanced expression of the epidermal growth factor receptor (EGFR) or its ligands, epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α) can increase signalling via receptor-mediated pathways which may lead to excessive proliferation and cellular transformation. Such autocrine regulation of growth has been demonstrated for prostate cancer cell lines in culture but its role in prostate cancerin vivo has not been established. To assess the potential of such a mechanism, we have examined the pathway components in prostate carcinomas (CaP) in comparison with non-malignant benign prostatic hyperplasias (BPH). In the present study, we investigate the dosage, structure and expression of EGF, TGF-α and EGFR genes in a series of 34 human prostate samples and 3 prostate cancer cell lines. All of the samples contained transcripts from each of the genes. The expression of pre-pro-TGF-α mRNA and pre-pro-EGF mRNA were significantly higher in CaP (n=13) than BPH (n=21) specimens (p<0.05). The androgen-responsive prostatic carcinoma cell line, LNCaP, expressed high levels of EGF mRNA while the androgen-independent DU145 and PC-3 cell lines expressed high levels of TGF-α mRNA and EGFR mRNA. In general, overexpression of these mRNAs was not associated with amplification or detectable gene rearrangment; only DU145 cells demonstrated any alteration in these genes, with apparent amplification of the TGF-α gene. Relative to BPH, all prostate carcinomas and cell lines studied had elevated levels of mRNA for one or both mRNA coding for the ligands for EGFR. Thus enhanced expression of the ligands and co-expression of the EGF receptor are frequent events in human prostate tumors, consistent with the cell culture data supporting autocrine growth regulation via EGFR-mediated pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56: 881–914, 1987

    Google Scholar 

  2. Carpenter G, Cohen S: Epidermal growth factor. Ann Rev Biochem 48: 193–216, 1979

    Google Scholar 

  3. Winkler ME, O'Connor L, Winget M, Fendly B: Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor. Biochemistry 28: 6373–6378, 1989

    Google Scholar 

  4. Stoscheck CM, King LEJ: Role of epidermal growth factor in carcinogenesis. Cancer Res 46: 1030–1037, 1986

    Google Scholar 

  5. Clark AJ, Ishii S, Richert N, Merlino GT, Pastan I: Epidermal growth factor regulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374–8378, 1985

    Google Scholar 

  6. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307: 521–527, 1984

    Google Scholar 

  7. Todaro GJ, Fryling C, Delarco JE: Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262, 1980

    Google Scholar 

  8. Mydlo JH, Michaeli J, Cordon Cardo C, Goldenberg AS, Heston WD, Fair WR: Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49: 3407–3411, 1989

    Google Scholar 

  9. Bennett C, Paterson IM, Corbishley CM, Luqmani YA: Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res 49: 2104–2111, 1989

    Google Scholar 

  10. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I et al.: High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46: 414–416, 1986

    Google Scholar 

  11. Filmus J, Pollak MN, Cailleau R, Buick RN: MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128: 898–905, 1985

    Google Scholar 

  12. Yoshida K, Kyo E, Tsujino T, Sano T, Niimoto M, Tahara E: Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res 81: 43–51, 1990

    Google Scholar 

  13. Sporn MB, Roberts AB: Peptide growth factors are multifunctional. Nature 332: 217–219, 1988

    Google Scholar 

  14. Sporn MB, Roberts AB: Autocrine, paracrine and endocrine mechanisms of growth control. Cancer Surv 4: 627–632, 1985

    Google Scholar 

  15. Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46: 1015–1029, 1986

    Google Scholar 

  16. Bruchovsky N, Wilson JD: The coversion of testosterone to 5a-androstan-17-ol-3-ne by rat prostatein vivo andin vitro. J Biol Chem 243: 2012–2021, 1968

    Google Scholar 

  17. Bruchovsky N, Wilson JD: The intranuclear binding of testosterone and 5-androstan-17-ol-3 one by rat prostate. J Biol Chem 243: 5953–5960, 1968

    Google Scholar 

  18. Wilson JD, George FW, Griffin JE: The hormonal control of sexual development. Science 211: 1278–1284, 1981

    Google Scholar 

  19. Bruchovsky N, Lesser B, Van Doorn E, Cravan S: Hormonal effects an cell proliferation in the rat prostate vitam. Horm 33: 61–100, 1975

    Google Scholar 

  20. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338–362, 1987

    Google Scholar 

  21. Gregory H, Willshire IR, Kavanagh JP, Blacklock NJ, Chowdury S, Richards RC: Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci 70: 359–363, 1986

    Google Scholar 

  22. Elson SD, Browne CA, Thorburn GD: Identification of epidermal growth factor-like activity in human male reproductive tissues and fluids. J Clin Endocrinol Metab 58: 589–594, 1984

    Google Scholar 

  23. Shaikh N, Lai L, McLoughlin J, Clark D, Williams G: Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance. Anticancer Res 10: 873–874, 1990

    Google Scholar 

  24. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707–712, 1987

    Google Scholar 

  25. Connolly JM, Rose DP: Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 15: 177–186, 1989

    Google Scholar 

  26. Connolly JM, Rose DP: Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209–218, 1990

    Google Scholar 

  27. Maddy SQ, Chisholm GD, Hawkins RA, Habib FK: Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocrinol 113: 147–153, 1987

    Google Scholar 

  28. Eaton CL, Davies P, Phillips ME: Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30: 341–345, 1988

    Google Scholar 

  29. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM: Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res 51: 2780–2785, 1991

    Google Scholar 

  30. Morris GL, Dodd JG: Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143: 1272–1274, 1990

    Google Scholar 

  31. Berns EM, de Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9: 247–259, 1986

    Google Scholar 

  32. Stone K, Mickey DD, Wunderli H, Mickey G, Paulson DF: Isolation of human prostate carcinoma cell line (DU145). Int J Cancer 21: 274–281, 1978

    Google Scholar 

  33. Kaighn NE, Narayna KS, Ohnuki K, Lechnert F, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 17: 6–23, 1979

    Google Scholar 

  34. Gleason DF: Histologic grading and clinical staging of prostatic cancer. In: M Tannenbaum (ed.) Urologic Pathology: The Prostate. Lea and Febiger, Philadelphia, 1977, pp 171–198

    Google Scholar 

  35. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning a laboratory manual. Cold Spring Harbor Laboratory Press, New York, 1990

    Google Scholar 

  36. Aviv H, Leder P: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 67: 1408–1412, 1977

    Google Scholar 

  37. Wilding G, Valverius E, Knabbe C, Gelmann EP: Role of transforming growth factor-alpha in human prostate cancer cell growth. Prostate 15: 1–12, 1989

    Google Scholar 

  38. Connolly JM, Rose DP: Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173–180, 1991

    Google Scholar 

  39. Murray JC, DeHaven CR, Bell GI: RFLPs for epidermal growth factor (EGF), a single copy sequence 4q25-4q27. Nucleic Acids Res 14: 5117–5121, 1986

    Google Scholar 

  40. Murphy LC, Tsuyuki D, Myal Y, Shiu RPC: Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). J Biol Chem 262: 15236–15341, 1987

    Google Scholar 

  41. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063–1070, 1987

    Google Scholar 

  42. Watanabe S, Lazar E, Sporn MB: Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying an synthetic rat type alpha transforming growth factor gene. Proc Natl Acad Sci USA 84: 1258–1262, 1987

    Google Scholar 

  43. Stern DF, Hare DL, Cecchini MA, Weinberg RA: Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 235: 321–324, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ching, K.Z., Ramsey, E., Pettigrew, N. et al. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126, 151–158 (1993). https://doi.org/10.1007/BF00925693

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00925693

Key words

Navigation